Consun Pharmaceutical Group LtdConsun Pharmaceutical Group Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Other companies in the rating industry group for Consun Pharmaceutical Group Ltd are shown. This page includes a Q&A table on Consun Pharmaceutical Group Ltd. Complete ESG analysis of Consun Pharmaceutical Group Ltd can be accessed by logging in.

Consun Pharmaceutical Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 6.4, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Consun Pharmaceutical Group Ltd 
Low
0 - 3
Medium
4 - 6

7.5

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Consun Pharmaceutical Group Ltd 
6.4

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
209WuXi AppTec Co Ltd
7.6
High
209Waters Corp
7.6
High
256Consun Pharmaceutical Group Ltd
7.5
High
256Acorda Therapeutics Inc
7.5
High
256Alkermes Plc
7.5
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Consun Pharmaceutical Group Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd offer flexible work?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose water use targets?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Consun Pharmaceutical Group Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Consun Pharmaceutical Group Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Consun Pharmaceutical Group Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Consun Pharmaceutical Group Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Consun Pharmaceutical Group Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Consun Pharmaceutical Group Ltd
These potential risks are based on the size, segment and geographies of the company.

Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.

Sorry!

Failed to process!